Skip to main content
Equibles
STRO logo

STRO · Sutro Biopharma, Inc. · Analyst Estimates

Track STRO — free

Use STRO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STRO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.20 -0.74 (-7.44%) At close · Nov 5
Russell 2000 member Rebalance outlook locked
Market Cap
$153.71M
Shares
16.58M
Volume · Nov 5 771.86K Avg daily vol (3M) 319.6K

Analyst Estimates

Compare analyst forecasts for Sutro Biopharma, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-06 01:39 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-8.57
-7.48
-6.39
2
-7.77
-7.77
-7.77
-8.47
0
0
1
2
Revenue
USD
Publication date not stated
29.36M
52.63M
124.40M
12
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-9.32
-6.11
-4.31
3
-6.21
-6.21
-6.21
-6.39
1
1
1
1
Revenue
USD
Publication date not stated
0.00
31.23M
69.24M
12
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.38
-1.96
-1.45
3
-2.07
-2.07
-2.07
-2.53
0
0
2
2
Revenue
USD
Publication date not stated
2.50M
14.12M
50.00M
12
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.46
-2.23
-1.87
3
-2.36
-2.36
-2.36
-2.65
1
1
1
1
Revenue
USD
Publication date not stated
-362,000.00
13.59M
50.00M
12
 — — — — — — — —
Key facts CIK 1382101 CUSIP 869367201 13F (30d) 31 filings 19 filers Visit website Investor relations